Skip to main content

A Study of (LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Color

Completed · Phase 3 · NCT05372419

Conditions: Atopic Dermatitis

At a glance

Research payments reported, 2025
$259,421
U.S. investigators named
32
Sites paid
33
Planned or actual enrollment
90

About the trial

Sponsor
Eli Lilly and Company
Tested
Lebrikizumab (drug)
Dates
Started 2023-01-12; completion 2025-02-17
Results posted
Yes

The main purpose of this study is to determine the safety and efficacy lebrikizumab in adolescent and adult participants with moderate-to-severe atopic dermatitis (AD) and skin of color.

From ClinicalTrials.gov, last updated 2026-03-09. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Eli Lilly and Company reported $259,421 in research payments for this study in 2025 (34 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Wallace Medical Group Inc $27,316
  • University of California Davis Medical Center, CA $17,444
  • Elias Research Associates LLC $14,410
  • Dorisca Research Consulting LLC $13,731
  • Revival Research Institute LLC $13,635
  • Yale University $12,155
  • Skin Specialists PC $12,019
  • Center for Dermatology Clinical Research Inc $11,991
  • Steven A Davis M D $10,584
  • Piedmont Medical Research Associates Inc $10,109
  • Avance Clinical Trials Inc $9,979
  • Cura Clinical Research LLC $9,621
  • Complete Dermatology $9,449
  • Encore Medical Research of Boynton Beach LLC $8,558
  • Pharmaseek Financial Services $8,263
  • Interspond LLC $7,996
  • Washington University $7,949
  • Dermatology Research Associates Inc $7,681
  • University of Connecticut Health $6,496
  • 113 Efficient Services $5,949
  • Dermatologic Surgical Specialists $5,517
  • Allcutis Research LLC $5,426
  • Clinical Trial Network LLC $4,550
  • University Clinical Research Deland LLC $3,800
  • Skin Care Research LLC $3,700
  • Total Vein and Skin LLC $3,500
  • Sadick Research Group LLC $2,805
  • Solutions Through Advanced Research $1,876
  • Dermatology Institute and Skin Care $1,500
  • Progressive Clinical Research $797
  • Advanced Medical Research Inc $525
  • Heartland Research Associates LLC $68
  • Avance Trials $22

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.